Product NDC: | 21695-411 |
Proprietary Name: | Ciprofloxacin |
Non Proprietary Name: | ciprofloxacin hydrochloride |
Active Ingredient(s): | 250 mg/1 & nbsp; ciprofloxacin hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 21695-411 |
Labeler Name: | Rebel Distributors Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076794 |
Marketing Category: | ANDA |
Start Marketing Date: | 20030819 |
Package NDC: | 21695-411-10 |
Package Description: | 10 TABLET in 1 BOTTLE (21695-411-10) |
NDC Code | 21695-411-10 |
Proprietary Name | Ciprofloxacin |
Package Description | 10 TABLET in 1 BOTTLE (21695-411-10) |
Product NDC | 21695-411 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ciprofloxacin hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20030819 |
Marketing Category Name | ANDA |
Labeler Name | Rebel Distributors Corp |
Substance Name | CIPROFLOXACIN HYDROCHLORIDE |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |